| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |